Get started
Author

Laura Horka

Observed names: Horka, Laura, Laura Maria Horka
ORCID: 0009-0009-1758-1714
Observed ORCID: 0009-0009-1758-1714
OpenAlex ID: A5038020320
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire
2022 · Sarah C. Grünert, Terry G.J. Derks, et al. · Genetics in Medicine · 65
PDF
Plasma concentrations of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
2023 · Patrick Pasi, Dino Kröll, et al. · Frontiers in Psychiatry · 10
PDF
Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center
2024 · Susanna Hofbauer, Laura Horka, et al. · Frontiers in Endocrinology · 7
LEMD2 ‐associated progeroid syndrome: Expanding the phenotype of the nuclear envelopathy caused by a defect in LEMD2 gene
2024 · Alyssia Matter, Christina Kaufman, et al. · Aging Cell · 6
PDF
The influence of menstrual cycle on metabolic control and diet in patients with phenylketonuria
2025 · Laura Horka, Kristin Landolt, et al. · Orphanet Journal of Rare Diseases · 3
PDF
Pharmacokinetics of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
2022 · Patrick Rodolphe Pasi, Dino Kröll, et al. · Research Square
PDF
Metabolic and inflammatory parameters for baseline characterization and treatment outcome of prolactinoma patients
2022 · Susanna Hofbauer, Matthias Ernst, et al. · Endocrine Abstracts
Works count: 11
Citation count: 91
H-index: 4
I10-index: 2
Year
Topic
Type